If I could give this post a thousand thumbs up I w
Post# of 148280
Quite frankly I don't care who is holding down the C-Suite as long as leronlimab gets approved and it's multiple potential indications will be explored. If the drug ends up being as good as touted, it would be a disservice to humanity to hold on to my favorite opinion as the only way to get things done. Not that I don't want to make a boatload of cash, but if you told me today that the 13D crowd was taking over and had a buyout lined up for 10 bucks a share from a big pharma that can get it done. I'm not complaining...I'm loading up at 1.77. If NP gets this across the goal line and creates unfathomable wealth, I'll take that too. Just get the dang no SAE drug out there so we don't have to see this biogen garbage in the headlines.
Good luck to all and may the Brasil trials fill fast and bring the drug to approvals quicker.